{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q8NE62",
      "entity_text" : "CHD",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q16473",
      "entity_text" : "Xa",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Therefore, antiplatelet therapy plus Xa factor inhibitors of CHD patients should give full consideration to its benefit and risk of bleeding.",
  "reading_complete" : "2020-08-04T17:22:41Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T17:20:57Z",
  "trigger" : "inhibitors",
  "evidence" : [ "Xa factor inhibitors of CHD" ],
  "pmc_id" : "6668492",
  "score" : 0
}